Evidence map›Paper›PMID 42884033›Full record

ReviewInternational journal of molecular sciences2026

Extracellular Vesicles for Corneal Endothelial Repair.

Ana Kolenc, Elvira Maličev, Zala Lužnik Marzidovšek

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ana KolencBlood Transfusion Centre of Slovenia, 1000 Ljubljana, Slovenia.
Elvira MaličevBlood Transfusion Centre of Slovenia, 1000 Ljubljana, Slovenia.
Zala Lužnik MarzidovšekEye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-3164-1586

Funding

The Slovenian Research and Innovation Agency J3-50107
6 · The paper itself

Abstract

The corneal endothelium is essential for maintaining corneal transparency and visual function through regulation of stromal hydration. However, human corneal endothelial cells have limited regenerative capacity in vivo, and their loss due to aging, trauma, surgery, or diseases such as Fuchs endothelial corneal dystrophy can lead to corneal oedema and visual impairment. Although corneal transplantation remains the primary treatment for endothelial dysfunction or loss, donor tissue shortages and postoperative complications have driven the search for alternative therapies. Extracellular vesicles (EVs) have emerged as promising cell-free therapeutic agents that mediate intercellular communication through the transfer of bioactive molecules. Recent studies have investigated two distinct EV sources in corneal endothelial biology: mesenchymal-stem-cell-derived EVs, which have demonstrated cytoprotective and regenerative effects, and corneal endothelial cell-derived EVs, which appear to modulate endothelial homeostasis and, depending on their cargo, may either limit proliferation or exert protective effects. This review summarizes current evidence on EV biology, their distinct cellular sources, and their potential roles in corneal endothelial repair.

Indexed as

Endothelium, CornealExtracellular VesiclesAnimalsHumansMesenchymal Stem CellsRegenerationcorneal endotheliumcorneal repairextracellular vesiclesmesenchymal stem cellsregenerative medicine

Identifiers

PMID42884033
PMCPMC13665309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.